Stocky turns companies like China Medical System Holdings L into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. CHSYF shows balanced but unexciting fundamentals: moderate Growth (40/100) and Value (49/100) scores suggest neither a compounder nor a deep value opportunity. Leadership Alignment (59/100) lacks the founder-ownership or capped dilution signals that drive real skin-in-the-game incentives. The Vulnerability Index (50/100) reveals thin financial buffers—adequate but not reassuring—leaving limited margin for error in downturns. A middling company at a fair price.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for China Medical System Holdings L:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 51/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates China Medical System Holdings L (CHSYF) at 51/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. CHSYF shows balanced but unexciting fundamentals: moderate Growth (40/100) and Value (49/100) scores suggest neither a compounder nor a deep value opportunity. Leadership Alignment (59/100) lacks the founder-ownership or capped di
CHSYF's current Stocky Verdict is 51/100, placing it in the "Cautious" band. This composite combines a 49/100 Compounder score, 59/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for China Medical System Holdings L yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
China Medical System Holdings L scores 59/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
China Medical System Holdings L's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to China Medical System Holdings L.
Sign up free and unlock the full analysis on CHSYF — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for CHSYF in the app.
